What's happening
This bill requires the Department of Health to annually publish public, machine-readable reports on opioid sales in New York, with some exceptions.
Why it matters
Enables greater transparency by requiring detailed annual reporting of opioid sales data. including quantities, strengths, and financials—accessible to the public, which may support research and public health responses to the opioid crisis.
Mandates that reports be provided in machine-readable formats. , facilitating data analysis, integration with other datasets, and use by journalists, policymakers, and advocacy groups.
Protects certain sensitive information. specifically, the identities of entities purchasing opioids (such as pharmacies or hospitals)—from public disclosure, potentially balancing transparency with privacy and security concerns.
Creates a standardized, recurring data release from the Department of Health. , ensuring that stakeholders have up-to-date, consistent information to monitor trends, identify anomalies, and inform policy or enforcement actions.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
New York State Department of Health
The bill would require the department to post opioid sales report data annually on its website in machine-readable formats, excluding buyer names, addresses and DEA registration numbers.
Registered opioid sellers
Their annual reports would remain required, and information including seller identifiers, sales receipts, drug quantities and morphine milligram equivalents would be publicly available.
Entities buying opioids from registrants
Their names, addresses and DEA registration numbers would be excluded from the information made public.
Opioid policy researchers and advocates
They would have access to annual machine-readable sales data on the Department of Health’s website to analyze opioid sales in New York.
Headline styles
Make Opioid Sales Reports Public
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Substituted by S821
- Ordered to third reading rules cal.15
- Rules report cal.15
- Reported
- Reported referred to rules
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Publish Opioid Sales Data
Signed by Governor · Sponsor Pete Harckham
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
996
2023-2024 Regular Sessions
IN ASSEMBLY
January 12, 2023
Introduced by M. of A. GONZALEZ-ROJAS -- read once and referred to the Committee on Health
AN ACT to amend the tax law, in relation to availability of certain reports detailing sales of opioids in this state
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision (g) of section 498 of the tax law, as amended by a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, is amended to read as follows:
(g) Each registrant shall provide a report to the department of health detailing all opioids sold by such registrant in the state of New York. Such report shall include:
(i) the registrant's name, address, phone number, federal Drug Enforcement Agency (DEA) registration number, education department registration number, and controlled substance license number issued by the department of health, if applicable;
(ii) the name, address and DEA registration number of the entity to whom the opioid was sold;
(iii) the date of the sale of the opioid;
(iv) the gross receipt total, in dollars, for each opioid sold;
(v) the name and National Drug Code of the opioid sold;
(vi) the number of containers and the strength and metric quantity of controlled substance in each container of the opioid sold;
(vii) the total number of morphine milligram equivalents sold; and
(viii) any other elements as deemed necessary by the commissioner of health.
Such information shall be reported [and published] annually in such form as defined by the commissioner of health and shall not be subject
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03968-01-3
to the provisions of section four hundred ninety-nine of this article[, with] . With the exception of the information collected under paragraph (ii) of this subdivision[. The], the department of health shall make the information collected in such [report shall be made] reports available to the public in machine-readable formats and [such report shall be made] make it publicly available on the department of health's website annually.
§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 amending the tax law relating to requiring the department of health to publish certain reports on department's website detailing sales of opioids sold in the state, as proposed in legislative bills numbers S. 7378-A and A. 8339-A, takes effect.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.